Xenetic holder MJL Manager reports 0% stake
Xenetic Biosciences, Inc. (XBIO) is the subject of a Schedule 13G filing by MJL Manager LLC and Michael Liu reporting that they currently hold no beneficial ownership of the company’s common stock.
Rhea-AI Filing Summary
Xenetic Biosciences, Inc. (XBIO) is the subject of a Schedule 13G filing by MJL Manager LLC and Michael Liu reporting that they currently hold no beneficial ownership of the company’s common stock. The filing lists 0 shares beneficially owned, representing 0% of the outstanding common stock, with no sole or shared voting or dispositive power.
Positive
- None.
Negative
- None.
Key Figures
Shares beneficially owned by MJL Manager LLC: 0 shares
Ownership percentage of MJL Manager LLC: 0%
Shares beneficially owned by Michael Liu: 0 shares
+3 more
6 metrics
Shares beneficially owned by MJL Manager LLC
0 shares
Common stock of Xenetic Biosciences, Inc.
Ownership percentage of MJL Manager LLC
0%
Percent of class of Xenetic Biosciences common stock
Shares beneficially owned by Michael Liu
0 shares
Common stock of Xenetic Biosciences, Inc.
Ownership percentage of Michael Liu
0%
Percent of class of Xenetic Biosciences common stock
Sole voting power (each reporting person)
0 shares
Sole power to vote or direct the vote
Shared voting power (each reporting person)
0 shares
Shared power to vote or direct the vote
Key Terms
beneficial ownership, Sole Voting Power, Shared Dispositive Power, Schedule 13G, +1 more
5 terms
beneficial ownership financial
"disclaims beneficial ownership except to the extent of such person's actual pecuniary interest"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Sole Voting Power financial
"5 | Sole Voting Power 0.00 6 | Shared Voting Power 0.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
Schedule 13G regulatory
"If a group has filed this schedule pursuant to 1(c) or 1(d)"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
percent of class financial
"Percent of class: MJL Manager LLC - 0% Michael Liu - 0%"
Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Schedule 13G filed for XBIO by MJL Manager LLC and Michael Liu report?
It reports that MJL Manager LLC and Michael Liu beneficially own 0 shares of Xenetic Biosciences common stock, representing 0% of the class, with no sole or shared voting or dispositive power.
AI-generated analysis. How Rhea-AI works. Not financial advice.